Introduction Adopting digital pathology isn’t just a tech upgrade. It’s a transformational shift in how labs deliver high quality services, achieve faster turnaround times, and most importantly, improve patient care. But a question often arises: How hard is it to implement? For many labs, concerns about lengthy, complex integrations, intensive staff training, and the added burden [...]
Author: Stacey Newton BVSc FRCPath CertEM (Int Med) PhD MRCVS A 7-year-old entire female Labrador was presented with a 2 cm round firm haired dermal mass on the left-hand side rostral lip. The duration of the mass was not indicated. Further investigation with fine-needle aspirates for cytology were performed. Cytology This demonstrated a predominant [...]
Techcyte, a leader in AI-powered digital pathology, has signed a distribution agreement with Hamamatsu Corporation (U.S.). This agreement enables Techcyte to streamline access to Hamamatsuʼs imaging systems for laboratories seeking to implement or expand digital pathology workflows. This agreement facilitates access to Hamamatsuʼs imaging systems as part of Techcyteʼs research use only (RUO) anatomic and clinical [...]
AIVIS, a leading provider of AI-powered digital pathology solutions, has announced a strategic partnership with NAVER Cloud to accelerate the deployment and adoption of its flagship software platform, Qanti® IHC, across Korea’s healthcare ecosystem. Through this collaboration, AIVIS’s AI pathology analysis solution, Qanti® IHC, will be available on the NAVER Cloud Platform Marketplace—enabling hospitals, research institutes, [...]
Author: Dr. Jennifer Horner, Global Product Marketing Manager, Evident Scientific Enabling extremely accurate and dynamically responsive sample analysis—and instantaneous data sharing and peer-to-peer consultation—digital pathology has firmly established itself at the forefront of modern diagnostic medicine. Today, when we talk about adopting digital pathology—and eventually embracing a completely digital clinical workflow—it’s not a question of [...]
Owkin, a global leader in AI-powered solutions for drug development and diagnostics, today announced a strategic agreement with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine, and France Tissue Bank (FTB). Owkin will leverage their respective high-quality histopathological datasets to develop the first foundation model exclusively trained on immunohistochemistry (IHC) images and [...]
Oncoclínicas&Co Utilizes Paige’s AI-Assisted Diagnostic Applications to Enhance Diagnostic Capabilities and Further Support Patient Safety Paige, a leader in next-generation AI technology, announced the continued and expanded use of its innovative AI-assisted diagnostic applications by long-time customer, Oncoclínicas&Co (Oncoclínicas), the largest private group of cancer care in Latin America. With a commitment to enhancing diagnostic [...]
Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements. The combined capabilities provide for comprehensive, flexible, [...]
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free optical imaging and computational pathology, today announced successful research demonstrating compatibility between illumiSonics’ research-use only Multi-Laser Imaging (MLI™) system and Modella AI’s research-use only PathChat™ DX platform, which has been granted a Breakthrough Device Designation by the [...]
As more laboratories transition from glass slides to images, one sometimes underestimated success factor is laboratory information system (LIS) integration. The LIS continues to underpin the diagnostic workflow, from accessioning and specimen tracking to sign-out. Yet most legacy LISs lack the flexibility to support digital pathology’s image-rich and data-driven workflows, turning them into a bottleneck rather [...]
